Headline Details

Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

Published on: Fri, 06 Jul 2018 7:28:16 UTC
News Agency: Reuters
Description:
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
Canadian PM says he is still puzzled by minister's resignation Reuters
Pence will meet with Lima Group on Venezuela: spokeswoman Reuters
Charity says 24 Polish bishops covered up sex abuses of minors Reuters
Corbyn says PM May must seek customs union with EU to unlock Brexit Reuters
Catalonia protesters clash with police over separatist trial Reuters